<DOC>
	<DOCNO>NCT00154427</DOCNO>
	<brief_summary>This trial conduct Africa , Asia , Europe , South America United States America ( USA ) . The trial plan investigate safety efficacy NovoSevenÂ® management post-operative bleeding patient follow cardiac surgery .</brief_summary>
	<brief_title>Use Activated Recombinant Human Factor VII Cardiac Surgery</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<criteria>Postoperative bleeding accord predefined criterion critical bleeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>